Roche and Eli Lilly to collaborate on early Alzheimer's detection test
A blood test, now being jointly developed between Roche and Eli Lilly, will help diagnose Alzheimer’s disease earlier.
by marketwire, translated by daniel pedersen
Swiss pharmaceutical company Roche and US-based Eli Lilly have joined forces to continue development of the former company’s Elecsys Amyloid Plasma Panel (EAPP) – an innovative blood test ”that aims to facilitate the earlier diagnosis of Alzheimer’s disease.”
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly Alzheimer’s drug fails to prevent disease in trial
For subscribers
